HuagongsheHuagongshe Chemistry Print Report · For research reference only
Acetaldehyde → 2-(3,4-Difluorophenyl)-3-methyl-3-hydroxypropionic acid
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Acetaldehyde | HCID 177 | — |
| Reactant | (3,4-Difluorophenyl)acetic acid | HCID 69571 | — |
| Reactant | Lithium diisopropylamide | HCID 2724682 | — |
| Reactant | 4(S)-(3,4-difluorophenyl)-5(S)-methyloxazolidin-2-one | HCID 10512750 | — |
| Product | 2-(3,4-Difluorophenyl)-3-methyl-3-hydroxypropionic acid | HCID 11481333 | — |
Reaction Steps
4(S)-(3,4-difluorophenyl)-5(S)-methyloxazolidin-2-one precursor to Compound A can be prepared by treating 3,4-difluorophenylacetic acid with LDA, followed by reaction with acetaldehyde to form 2-(3,4-difluorophenyl)-3-methyl-3-hydroxypropionic acid, and then cyclizing the hydroxypropionic acid with diphenyldiphosphorylazide to form the oxazolidinone. The oxazolidinone can then be activated by treatment with p-nitrophenylchloroformate. The oxazolidinones can be resolved into their optical isomers via chromatography prior to activation, or the unresolved material can be activated directly. The activated oxazolidinone is then acylated to give Compound A by treatment with 3-[4-(4-fluorophenyl)piperidin-1-yl]propylamine.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06329393B1 |
| Source dataset | uspto-grants-2001_12 |
| ORD ID | ord-87a5df08da08400ea63eb766a28cd78a |
| Source note | uspto-grants-2001_12 |